<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>, cerebrovascular <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo>, is often a variant of the "primary" anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>We report a woman with PAPS, presenting as <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>, with <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> and glomerular <z:mp ids='MP_0005048'>thrombosis</z:mp> on renal biopsy </plain></SENT>
<SENT sid="2" pm="."><plain>An IgG anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibody (aCL) was identified </plain></SENT>
<SENT sid="3" pm="."><plain>The aCL was purified by affinity chromatography, gel filtration chromatography and ion-exchange chromatography, assayed in a modified ELISA and found to be of the type that requires the plasma protein beta 2-GPI to bind aCL </plain></SENT>
<SENT sid="4" pm="."><plain>As beta 2-GPI has <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> properties it is postulated that its interaction with aCL has a pathogenic role in the thrombotic lesions associated with aCL </plain></SENT>
</text></document>